换一批Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the identification of antagonistic combinations: Implications for future clinical trials in pancreatic cancer.
第一作者：
Tanzeel,Khan
第一单位：
School of Life Science, Pharmacy and Chemistry, Kingston University London, Surrey KT1 2EE, UK.
作者：
主题词
抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);细胞周期(Cell Cycle);细胞系, 肿瘤(Cell Line, Tumor);细胞运动(Cell Movement);细胞增殖(Cell Proliferation);临床试验(主题)(Clinical Trials as Topic);细胞周期蛋白质依赖激酶类(Cyclin-Dependent Kinases);药物拮抗作用(Drug Antagonism);药物筛选试验, 抗肿瘤(Drug Screening Assays, Antitumor);药物协同作用(Drug Synergism);人类(Humans);半数抑制浓度(Inhibitory Concentration 50);胰腺肿瘤(Pancreatic Neoplasms);蛋白激酶抑制剂(Protein Kinase Inhibitors);受体, 生长因子(Receptors, Growth Factor);研究设计(Research Design)
DOI
10.3892/or.2020.7822
PMID
33125153
发布时间
2021-09-20
- 浏览4
Oncology reports
2581-2594页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
